“…Due to the complexity of mechanisms and to variability of in vivo responses (Leroux‐Roels et al., ; Table ), focusing on specific changes in either innate or adaptive immunity leads to incorrect conclusions about peptide activities, which can be corrected by measuring changes in both adaptive and innate immunities (Maestri et al., ). Anti‐inflammatory activity can be determined in vivo by the paw edema test, measuring swelling (as change in volume) after injection of inflammatory substance (Tavares et al., ), or in vitro by monitoring macrophage activity using chemiluminescence assays (changes in respiratory burst; Tompa et al., ), cytokine secretion (usually by ELISA; Tompa et al., ), or by monitoring monocyte adhesion to vascular endothelium (Aihara et al., ). Antiallergenic properties are measured in vitro determining IgE content by the reverse enzyme allergosorbent, ELISA, or enzyme allergosorbent tests (Falagiani et al., ; Wigotzki, Steinhart, & Paschke, ), or in vivo by measuring indexes of spleen and thymus status, such as changes in weight, hemolysin content, changes in optical density as a result of macrophage activity, and release of histamine from mast cells (Pan et al., ).…”